Ignite Creation Date:
2024-05-05 @ 10:47 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01189383
Status:
COMPLETED
Last Update Posted:
2016-12-22
First Post:
2010-08-25
Brief Title:
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III A B or C or Stage IV Melanoma
Sponsor:
Baylor Research Institute
Organization:
Baylor Research Institute